We are live on
!
Find out more
WSL
Western Standard LLC Portfolio holdings
AUM
$190M
1-Year Est. Return
40.88%
This Fund
S&P 500
This Quarter
Est. Return
+8.85%
1 Year Est. Return
+40.88%
3 Year Est. Return
+68.87%
5 Year Est. Return
+221.93%
10 Year Est. Return
–
AUM
$150M
AUM Growth
+$39.5M
(+36%)
Cap. Flow
+$28M
Cap. Flow
% of AUM
18.66%
Top 10 Holdings %
Top 10 Hldgs %
80.23%
Holding
39
New
11
Increased
8
Reduced
9
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atmus Filtration Technologies
ATMU
|
+$4.16M |
| 2 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$3.52M |
| 3 |
EQC
Equity Commonwealth
EQC
|
+$2.77M |
| 4 |
Fidelity National Information Services
FIS
|
+$2.74M |
| 5 |
Abeona Therapeutics
ABEO
|
+$2.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dole
DOLE
|
+$8.99M |
| 2 |
Douglas Dynamics
PLOW
|
+$5.31M |
| 3 |
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
|
+$4.38M |
| 4 |
iRhythm Holdings
IRTC
|
+$3.46M |
| 5 |
HealthStream
HSTM
|
+$3.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.91% |
| 2 | Energy | 8.95% |
| 3 | Financials | 7.9% |
| 4 | Materials | 5.55% |
| 5 | Consumer Discretionary | 4.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
iRhythm Holdings
IRTC
$3.69B
| $634K | 0.42% |
5,924
-39,732
| -87% | -$3.46M |
|
27
First Bancorp
FBP
$4.39B
| $617K | 0.41% |
+37,500
| New | +$554K |
|
28
NI Holdings
NODK
$324M
| $463K | 0.31% |
35,635
| – | – |
|
|
TECX
29
Tectonic Therapeutic
TECX
$578M
| $426K | 0.28% |
26,076
+213
| +0.8% | +$3.66K |
|
30
AngioDynamics
ANGO
$565M
| $419K | 0.28% |
+53,487
| New | +$371K |
|
31
J. Jill
JILL
$261M
| $360K | 0.24% |
13,945
| – | – |
|
32
Bioventus
BVS
$843M
| – | – |
-281,413
| Closed | -$929K |
|
|
33
Dole
DOLE
$1.34B
| – | – |
-776,106
| Closed | -$8.99M |
|
34
Gen Digital
GEN
$16.1B
| – | – |
-121,448
| Closed | -$2.15M |
|
35
CPI Card Group
PMTS
$235M
| – | – |
-52,396
| Closed | -$970K |
|
36
Instil Bio
TIL
$48.5M
| – | – |
-89,849
| Closed | -$769K |
|
37
Xponential Fitness
XPOF
$278M
| – | – |
-66,700
| Closed | -$1.03M |
|
38
Q32 Bio
QTTB
$452M
| – | – |
-13,892
| Closed | -$293K |
|
|
VGR
39
DELISTED
Vector Group Ltd.
VGR
| – | – |
-265,418
| Closed | -$2.82M |
|
Similar funds
RCAP
HCM
CFA
CCA
G
BC
SCM
BCPWM
Western Standard LLC's Q4 2023 Portfolio in Review
As of Q4 2023, Western Standard LLC held 39 positions worth $150M, up 36% from $111M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Western Standard LLC deployed $28M of net new capital in Q4 2023, opening 11 new positions and adding to 8 existing holdings. Its largest new stake was Atmus Filtration Technologies: 194,209 shares worth $4.56M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 42% a quarter earlier, followed by Energy and Financials.
On the sell side, the largest reduction was Douglas Dynamics, an estimated $5.31M trimmed.
- Western Standard LLC's largest Q4 2023 buy was Atmus Filtration Technologies: 194,209 shares worth $4.56M.
- Western Standard LLC added most to Merrimack Pharmaceuticals, Inc. in Q4 2023, an estimated $3.52M increase.
- Western Standard LLC's biggest Q4 2023 reduction was Douglas Dynamics, cutting an estimated $5.31M.
- Western Standard LLC fully exited Dole in Q4 2023, selling an estimated $8.99M.
- Western Standard LLC's ten largest holdings make up 80% of its $150M portfolio in Q4 2023.
- Western Standard LLC opened 11 new positions and closed 8 in Q4 2023.
- Western Standard LLC's portfolio value rose 36% quarter-over-quarter to $150M.
Based on Western Standard LLC's 13F filing for Q4 2023, filed 14 Feb 2024.